Hostname: page-component-848d4c4894-4hhp2 Total loading time: 0 Render date: 2024-06-03T11:48:33.142Z Has data issue: false hasContentIssue false
  • English
  • Français

Myopathies in the Intensive Care Unit

Published online by Cambridge University Press:  18 September 2015

Douglas Zochodne
Douglas Zochodne*
Affiliation:
Department of Clinical Neurosciences, University of Calgary, Calgary
*
University of Calgary, Department of Clinical Neurosciences, Room 182A, 3330 Hospital Drive N.W., Calgary, Alberta, Canada T2N4N1
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Myopathies that occur in the intensive care unit can be divided into preexisting myopathies or newly acquired myopathies that develop in the intensive care unit. Myotonic dystrophy is an example of a preexisting myopathy that may render patients susceptible to acute respiratory failure following surgical procedures and anaesthesia. A group of myopathies that develop within the intensive care unit have been labelled acute necrotizing myopathy of intensive care, thick filament myopathy and acute steroid myopathy. Corticosteroids and nondepolarizing muscle blocking agents may play a role in their development.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 25 , Issue S1 , February 1998 , pp. S40 - S42
Copyright
Copyright © Canadian Neurological Sciences Federation 1998

References

REFERENCES

1.Zochodne, DW, Bolton, CF. Neuromuscular disorders in Critical Illness. In: Bolton, CF, Young, GB, eds. Ballier’s Clinical Neurology. Critical Care, 1996; 5: 645–671.Google ScholarPubMed
2.Kohn, NN, Faires, JS, Rodman, T. Unusual manifestation due to involvement of involuntary muscle in dystrophica myotonica. N Engl J Med 1964; 271: 1179–1183.CrossRefGoogle Scholar
3.Coccagna, G, Mantovani, M, Parchi, C, Mironi, F, Lugaresi, E. Alveolar hypoventilation and hypersomnia in myotonic dystrophy. J Neurol Neurosurg Psychiatry 1975; 38:977–984.CrossRefGoogle ScholarPubMed
4.Carroll, JE, Zwillich, CW, Weil, JV. Ventilatory response in myotonic dystrophy. Neurology 1977; 27: 1125–1128.CrossRefGoogle ScholarPubMed
5.Ono, S, Kanda, F, Takahashi, K, et al. Neuronal loss in the medullary reticular formation in myotonic dystrophy: a clinicopathological study. Neurology 1996; 46: 228–231.CrossRefGoogle ScholarPubMed
6.Moufarrej, NA, Bertorini, TE. Respiratory insufficiency in adulttype acid maltase deficiency. South Med J 1993; 86: 560–567.CrossRefGoogle ScholarPubMed
7.Keunen, RW, Lambregts, PC, Op de Coul, AA, Joosten, EM, Respiratory failure as initial symptom of acid maltase deficiency. J Neurol Neurosurg Psychiatry 1984; 47: 549–552.CrossRefGoogle ScholarPubMed
8.Rosenow, EC, Engel, AG. Acid maltase deficiency in adults presenting as respiratory failure. Am J Med 1978; 64: 485–491.CrossRefGoogle ScholarPubMed
9.Di Mauro, S, Stern, LZ, Mehler, M, Nagle, RB, Payne, C. Adult onset acid maltase deficiency: a post-mortem study. Muscle Nerve 1978; 1: 27–36.CrossRefGoogle Scholar
10.Engel, AG, Gomez, MR, Seybold, ME, Lambert, EH. The spectrum and diagnosis of acid maltase deficiency. Neurology 1973; 23: 95–106.CrossRefGoogle ScholarPubMed
11.Angelini, C, Engel, AG. Comparative study of acid maltase deficiency. Biochemical differences between infantile, childhood, and adult types. Arch Neurol 1972; 26: 344–349.CrossRefGoogle ScholarPubMed
12.Karpati, G, Carpenter, S, Eisen, A, Aube, M, DiMauro, S. The adult form of acid maltase (alpha-1, 4-glucosidase) deficiency. Ann Neurol 1977; 1: 276–280.CrossRefGoogle ScholarPubMed
13.Loonen, MC, Busch, HFM, Koster, JF, et al. A family with different clinical forms of acid maltase deficiency (glycogenosis type II): biochemical and genetic studies. Neurology 1981; 31: 1209–1216.CrossRefGoogle ScholarPubMed
14.Swash, M, Schwartz, MS, Apps, MCP. Adult onset acid maltase deficiency. Distribution and progression of clinical and pathological abnormality in a family. J Neurol Sci 1985; 68:61–74.CrossRefGoogle ScholarPubMed
15.Wijdicks, EFM. Neurology of Critical Illness. Davis FA, Philadelphia, 1995.Google Scholar
16.Joutel, A, Moulonguet, A, Demaugre, F, et al. Type II carnitine palmitoyl transferase deficiency complicated by acute respiratory failure. Rev Neurol 1993; 149: 797–799.Google ScholarPubMed
17.Barohn, RJ, Clanton, T, Sahenk, Z, Mendell, JR. Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies. Neurology 1990; 40: 103–106.CrossRefGoogle ScholarPubMed
18.Robertson, PL, Roloff, DW. Chronic respiratory failure in limb-girdle muscular dystrophy: successful long-term therapy with nasal bilevel positive airway pressure. Pediatr Neurol 1994; 10: 328–331.CrossRefGoogle ScholarPubMed
19.Altobellis, SS, Roy, TM, Joyce, BW, Byrd, RP 3rd. Respiratory failure and death from HIV-associated myopathy. J Ky Med Assoc 1992; 90: 174–177.Google ScholarPubMed
20.Dewberry, RG, Schneider, BF, Cale, WF, Phillips, LH 2nd. Sarcoid myopathy presenting with diaphragm weakness. Muscle Nerve 1993; 16: 832–835.CrossRefGoogle ScholarPubMed
21.Fu, ES, Scharf, JE, Mangar, D, Miller, WD. Malignant hyperthermia involving the administration of desflurane. Can J Anaesth 1996; 43: 687–690.CrossRefGoogle ScholarPubMed
22.DeVere, R, Bradley, WG. Polymyositis: its presentation, morbidity, and mortality. Brain 1975; 98: 637–666.CrossRefGoogle ScholarPubMed
23.Howard, RS, Wiles, CM, Hirsch, NP, Spencer, GT. Respiratory involvement in primary muscle disorders: assessment and management. Q J Med 1993; 86: 175–189.Google ScholarPubMed
24.Gravelyn, TR, Brophy, N, Siegert, C, Peters-Golden, M. Hypophosphatemia associated respiratory muscle weakness in a general inpatient population. Am J Med 1988; 84: 870–876.CrossRefGoogle Scholar
25.Davis, MJ, Cilo, M, Plaitakis, A, Yahr, MD. Trichinosis; severe myopathic involvment with recovery. Neurology 1976; 26: 37–40.CrossRefGoogle ScholarPubMed
26.Zochodne, DW, Ramsay, DA, Saly, V, Shelley, S, Moffatt, S. Acute necrotizing myopathy of intensive care: electrophysiological studies. Muscle Nerve 1994; 17: 285–292.CrossRefGoogle ScholarPubMed
27.Hirano, M, Ott, BR, Raps, EC, et al. Acute quadriplegic myopathy: a complication of treatment with steroids, nondepolarizing blocking agents, or both. Neurology 1992; 42: 2082–2087.CrossRefGoogle ScholarPubMed
28.Minetti, C, Hirano, M, Morreale, G, et al. Ubiquitin expression in acute steroid myopathy with loss of myosin thick filaments. Muscle Nerve 1996; 19: 94–96.3.0.CO;2-3>CrossRefGoogle ScholarPubMed
29.Ramsay, DA, Zochodne, DW, Robertson, DM, Nag, S, Ludwin, SK. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 1993; 52: 387–398.CrossRefGoogle ScholarPubMed
30.Segredo, V, Caldwell, JE, Matthay, MA, et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327: 524–528.CrossRefGoogle ScholarPubMed
31.Danon, MJ, Carpenter, S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991; 14: 1131–1139.CrossRefGoogle ScholarPubMed
32.Henrich, WL, Prophet, D, Knochel, JP. Rhabdomyolysis associated with Escherichia coli septicemia. South Med J 1980; 73: 936–937.CrossRefGoogle ScholarPubMed
33.Ho, KJ, Scully, KT. Acute rhabdomyolysis and renal failure in Weil’s disease. Ala J Med Sci 1980; 17: 133–137.Google ScholarPubMed
34.Johnson, WD Jr, Silva, IC, Rocha, H. Serum creatine phosphokinase in Ieptospirosis. JAMA 1975; 233: 981–982.CrossRefGoogle Scholar
35.Posner, MR, Caudill, MA, Brass, R, Ellis, E. Legionnaire’s disease associated with rhabdomyolysis and myoglobinuria. Arch Intern Med 1980; 140: 848–850.CrossRefGoogle ScholarPubMed
36.Adamski, GB, Garin, EH, Ballinger, WE, Shulman, ST. Generalized nonsuppurative myositis with staphylococcal septicemia. J Pediatr 1980; 96: 694–697.CrossRefGoogle ScholarPubMed
37.Armstrong, JH. Tropical pyomyositis and myoglobinuria. Arch Intern Med 1978; 138: 1145–1146.CrossRefGoogle ScholarPubMed
38.Lannigan, R, Austin, TW, Vestrup, J. Myositis and rhabdomyolysis due to Staphylococcus aureus septicemia. J Infect Dis 1984; 150: 784.CrossRefGoogle ScholarPubMed
39.Bolton, CF, Young, GB, Zochodne, DW. Neurological changes during severe sepsis. In: Dobbs, GJ, ed. Current Topics in Intensive Care 1. Philadelphia: Saunders WS, 1994; 180–217.Google Scholar